NCT06947265View on ClinicalTrials.gov

Safety And Efficacy Of L-Arginine Monotherapy Versus Tadalafil Monotherapy Versus Their Combination In Men With Erectile Dysfunction; A Prospective Randomized Study

PHASE4CompletedINTERVENTIONAL

Enrollment

180

Participants

Timeline

Start Date

January 14, 2024

Primary Completion Date

January 1, 2025

Study Completion Date

February 1, 2025

Conditions

Erectile Dysfunctions

Interventions

DRUG

L-Arginine

get 3 gm oral tablets of L-arginine

DRUG

Tadalafil 5 mg

get 5 mg oral tadalafil for 8 weeks

Trial Locations (1)

63514

Mohamed Mahmoud Dogha, Al Fayyum

All Listed Sponsors

lead

Fayoum University Hospital

OTHER

NCT06947265 - Safety And Efficacy Of L-Arginine Monotherapy Versus Tadalafil Monotherapy Versus Their Combination In Men With Erectile Dysfunction; A Prospective Randomized Study | Biotech Hunter | Biotech Hunter